The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Roles of ROS in Cancer Heterogeneity and Therapy
Open accessAbstract
Cancer comprises a group of heterogeneous diseases encompassing high rates of morbidity and mortality. Heterogeneity, which is a hallmark of cancer, is one of the main factors related to resistance to chemotherapeutic agents leading to poor prognosis. Heterogeneity is profoundly affected by increasing levels of ROS. Under low concentrations, ROS may function as signaling molecules favoring tumorigenesis and heterogeneity, while under high ROS concentrations, these species may work as cancer modulators due to their deleterious, genotoxic or even proapoptotic effect on cancer cells. This double‐edged sword effect represented by ROS relies on their ability to cause genetic and epigenetic modifications in DNA structure. Antitumor therapeutic approaches may use molecules that prevent the ROS formation precluding carcinogenesis or use chemical agents that promote a sudden increase of ROS causing considerable oxidative stress inside tumor mass. Therefore, herein, we review what ROS are and how they are produced in normal and in cancer cells while providing an argumentative discussion about their role in cancer pathophysiology. We also describe the various sources of ROS in cancer and their role in tumor heterogeneity. Further, we also discuss some therapeutic strategies from the current landscape of cancer heterogeneity, ROS modulation, or ROS production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Reactive oxygen species: role in the development of cancer and various chronic conditions.
Waris, G., & Ahsan, H. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-14 · Cited by 1,459
Schagger, H., Cramer, W. A., & Vonjagow, G. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1112 · Cited by 1,238
Biochemical, physiological and medical aspects of ubiquinone function
Ernster, L., & Dallner, G. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00028-3 · Cited by 1,227
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 2×
“Structural modifications in complex I play a crucial role in ROS production mechanism [26].”
BackgroundThe Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044 · cited 1×
“Desmoplasia creates an auspicious microenvironment for tumor proliferation by originating a hypoxic and acidic niche as well as generating a mechanical stretch that is responsible for converting fibroblast to myofibroblast that also contributes to cancer heterogeneity and drug resistance [16].”
BackgroundBiology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997
Burton, G. J., & Jauniaux, E. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.016 · Cited by 988
Cancer heterogeneity: implications for targeted therapeutics
Fisher, R., Pusztai, L., & Swanton, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.581 · Cited by 978
Biological Diversity in Metastatic Neoplasms: Origins and Implications
Fidler, I. J., & Hart, I. R. (1982) · Science · doi:10.1126/science.7112116 · Cited by 928
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Jang, Y.-Y., & Sharkis, S. J. (2007) · Blood · doi:10.1182/blood-2007-05-087759 · Cited by 894
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Cadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Cancer cell killing via ROS: To increase or decrease, that is the question
Wang, J., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7067 · Cited by 790
Oxidant and antioxidant balance in the airways and airway diseases
Rahman, I., Biswas, S. K., & Kode, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.087 · Cited by 727
NADPH Oxidases, Reactive Oxygen Species, and Hypertension
Paravicini, T. M., & Touyz, R. M. (2008) · Diabetes Care · doi:10.2337/dc08-s247 · Cited by 724
Babior, B. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.12.001 · Cited by 705
KUSHNAREVA, Y., MURPHY, A. N., & ANDREYEV, A. (2002) · Biochemical Journal · doi:10.1042/bj20021121 · Cited by 677
Stem cells and the impact of ROS signaling
Bigarella, C. L., Liang, R., & Ghaffari, S. (2014) · Development · doi:10.1242/dev.107086 · Cited by 632
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Transcriptional regulation of cell polarity in EMT and cancer
Moreno-Bueno, G., Portillo, F., & Cano, A. (2008) · Oncogene · doi:10.1038/onc.2008.346 · Cited by 610
Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
Ziech, D., Franco, R., Pappa, A., & Panayiotidis, M. I. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.015 · Cited by 568
Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts
von Zglinicki, T., Pilger, R., & Sitte, N. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00207-5 · Cited by 546 · cited 1×
“In addition to the discussion above, high levels of ROS may still lead to 8-oxoGua accumulation in telomeres, mainly because in humans these regions are typically constituted by 10–15 kb multiple repeated sequences composed by in-tandem (TTAGGG)n hexanucleotide repeats [98].”
BackgroundInhibitors of NADH–ubiquinone reductase: an overview
Degli Esposti, M. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00029-2 · Cited by 528
Cellular Heterogeneity and Molecular Evolution in Cancer
Almendro, V., Marusyk, A., & Polyak, K. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163923 · Cited by 498
Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state
Starkov, A. A., & Fiskum, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01908.x · Cited by 492
Role of Mitochondria in Oxidative Stress and Aging
LENAZ, G., BOVINA, C., D'AURELIO, M., FATO, R., FORMIGGINI, G., GENOVA, M. L., GIULIANO, G., PICH, M. M., PAOLUCCI, U., CASTELLI, G. P., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02094.x · Cited by 490
Lambert, A. J., & Brand, M. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406576200 · Cited by 480
LAMBERT, A. J., & BRAND, M. D. (2004) · Biochemical Journal · doi:10.1042/bj20040485 · Cited by 470
Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., & Ruggiero, F. M. (2004) · Circulation Research · doi:10.1161/01.res.0000109416.56608.64 · Cited by 468
Mitochondrial respiratory complex I: Structure, function and implication in human diseases
Sharma, L., Lu, J., & Bai, Y. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787846578 · Cited by 438 · cited 1×
“Cancer cells accumulate alterations in mitochondrial genome, dysregulations in mitochondrial respiration, and increased ROS production, feeding back oxidative injuries and maybe increasing mtDNA mutation rate [40].”
BackgroundTumour heterogeneity and the evolution of polyclonal drug resistance
Burrell, R. A., & Swanton, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.005 · Cited by 417
Gisselsson, D., Jonson, T., Petersén, Å., Strömbeck, B., Dal Cin, P., Höglund, M., Mitelman, F., Mertens, F., & Mandahl, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211357798 · Cited by 416
Chabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., & Wilcox, C. S. (2002) · Hypertension · doi:10.1161/hy0202.103264 · Cited by 377
Moore, N., & Lyle, S. (2011) · Journal of Oncology · doi:10.1155/2011/396076 · Cited by 372
Chalovich, J. M., & Eisenberg, E. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34942-1 · Cited by 349
DNA damage by reactive species: Mechanisms, mutation and repair
Jena, N. R. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9218-2 · Cited by 344
Reactive Oxygen Species in Cancer Stem Cells
Shi, X., Zhang, Y., Zheng, J., & Pan, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4529 · Cited by 325
Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Sun, X.-X., & Yu, Q. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.92 · Cited by 318
Poste, G., Doll, J., & Fidler, I. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6226 · Cited by 301
Takeshige, K., & Minakami, S. (1979) · Biochemical Journal · doi:10.1042/bj1800129 · Cited by 298
Genova, M. L., Ventura, B., Giuliano, G., Bovina, C., Formiggini, G., Parenti Castelli, G., & Lenaz, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02850-2 · Cited by 298
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
Opresko, P. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki273 · Cited by 289
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286 · cited 5×
“Adaptive stress responses occurring in certain tumor cells may include the activation of redox-sensitive Nrf2, promoting an increase in the expression of ROS-scavenging enzymes, increasing the levels of prosurvival factors and inhibiting cell death factors.”
BackgroundInfluentialImplications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis
Lu, J., Sharma, L. K., & Bai, Y. (2009) · Cell Research · doi:10.1038/cr.2009.69 · Cited by 278
The sirtuins, oxidative stress and aging: an emerging link
Merksamer, P. I., Liu, Y., He, W., Hirschey, M. D., Chen, D., & Verdin, E. (2013) · Aging · doi:10.18632/aging.100544 · Cited by 275
Touyz, R. M., Yao, G., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000069236.27911.68 · Cited by 270
Mitochondrial energy metabolism and ageing
Bratic, I., & Trifunovic, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.004 · Cited by 269
Petrosillo, G., Francesca, M. R., Di Venosa, N., & Paradies, A. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0729fje · Cited by 261
An analysis of the role of coenzyme Q in free radical generation and as an antioxidant
Beyer, R. E. (1992) · Biochemistry and Cell Biology · doi:10.1139/o92-061 · Cited by 251
A threshold concept for cancer therapy
Kong, Q., Beel, J. A., & Lillehei, K. O. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0982 · Cited by 250
Nakagawa, H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh168 · Cited by 249
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
Torti, D., & Trusolino, L. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100176 · Cited by 246
Genomic Instability in Cancer: Teetering on the Limit of Tolerance
Andor, N., Maley, C. C., & Ji, H. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1553 · Cited by 242
Role of Oxidative Stress in Stem, Cancer, and Cancer Stem Cells
Dayem, A. A., Choi, H.-Y., Kim, J.-H., & Cho, S.-G. (2010) · Cancers · doi:10.3390/cancers2020859 · Cited by 229
NADPH oxidases: New kids on the block
GEISZT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.004 · Cited by 215
Jiang, N., Huang, J., Edwards, L. J., Liu, B., Zhang, Y., Beal, C. D., Evavold, B. D., & Zhu, C. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.017 · Cited by 210
Mitochondrial ROS and cancer drug resistance: Implications for therapy
Okon, I. S., & Zou, M.-H. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.013 · Cited by 207
Biological Effects of 5-Azacytidine in Eukaryotes
Čihák, A. (1974) · Oncology · doi:10.1159/000224981 · Cited by 201
Coluzzi, E., Colamartino, M., Cozzi, R., Leone, S., Meneghini, C., O’Callaghan, N., & Sgura, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110963 · Cited by 197
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
Diaz-Cano, S. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021951 · Cited by 169
Oxidative Stress and DNA Methylation in Prostate Cancer
Donkena, K. V., Young, C. Y. F., & Tindall, D. J. (2010) · Obstetrics and Gynecology International · doi:10.1155/2010/302051 · Cited by 168
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
Albini, A., Bruno, A., Gallo, C., Pajardi, G., Noonan, D. M., & Dallaglio, K. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1066780 · Cited by 166
Du, G., Mouithys-Mickalad, A. A., & Sluse, F. E. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00148-8 · Cited by 165
Intratumoral Heterogeneity: From Diversity Comes Resistance
Pribluda, A., de la Cruz, C. C., & Jackson, E. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1213 · Cited by 161
Clinical and biological effects of demethylating agents on solid tumours – A systematic review
Linnekamp, J. F., Butter, R., Spijker, R., Medema, J. P., & van Laarhoven, H. W. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.01.004 · Cited by 160
Lu, C., Qin, L., Liu, H.-C., Candas, D., Fan, M., & Li, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121046 · Cited by 154
Complexity of cancer stem cells
Sugihara, E., & Saya, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27961 · Cited by 153
Singh, A. K., Arya, R. K., Maheshwari, S., Singh, A., Meena, S., Pandey, P., Dormond, O., & Datta, D. B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28804 · Cited by 152
Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
Arcucci, A., Ruocco, M. R., Granato, G., Sacco, A. M., & Montagnani, S. (2016) · BioMed Research International · doi:10.1155/2016/4502846 · Cited by 152
Herrero, A., & Barja, G. (2000) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005626712319 · Cited by 150
Involvement of oxidatively damaged DNA and repair in cancer development and aging.
Tudek, B., Winczura, A., Janik, J., Siomek, A., Foksiński, M., & Oliński, R. (2010) · PubMed · Cited by 143
Links between cancer stem cells and epithelial– mesenchymal transition
Tang, Y., Wang, S., Jiang, J. D., & Liang, X. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s91863 · Cited by 143
Mitochondrial proticity and ROS signaling: lessons from the uncoupling proteins
Mailloux, R. J., & Harper, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.004 · Cited by 126
The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation
Kim, E., Kim, N., & Cho, S. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.2 · Cited by 119
Mitochondria, oxidative stress, and antioxidant defences.
Lenaz, G., Bovina, C., Formiggini, G., & Castelli, G. P. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4179 · Cited by 99
Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance
Kang, K. A., & Hyun, J. W. (2017) · Toxicological Research · doi:10.5487/tr.2017.33.1.001 · Cited by 95
Makker, A., & Goel, M. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0218 · Cited by 91
How does the metabolism of tumour cells differ from that of normal cells
Amoêdo, N. D., Valencia, J. P., Rodrigues, M. F., Galina, A., & Rumjanek, F. D. (2013) · Bioscience Reports · doi:10.1042/bsr20130066 · Cited by 90
Hajas, G., Bácsi, A., Aguilera-Aguirre, L., Hegde, M. L., Tapas, K. H., Sur, S., Radak, Z. O., Ba, X., & Boldogh, I. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.011 · Cited by 88
Kimura, T., Nakamura, T., Murayama, K., Umehara, H., Yamano, N., Watanabe, S., Taketo, M. M., & Nakano, T. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.06.038 · Cited by 87
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Issa, M. E., Takhsha, F. S., Chirumamilla, C. S., Perez-Novo, C. A., Berghe, W. V., & Cuendet, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0319-5 · Cited by 82
The Bad, the Good, and the Ugly about Oxidative Stress
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/163913 · Cited by 73
Genetic determinants of oxidative stress‐mediated sensitization of drug‐resistant cancer cells
Maiti, A. K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26306 · Cited by 72
E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling
Dominguez‐Brauer, C., Khatun, R., Elia, A., Thu, K. L., Ramachandran, P., Baniasadi, S. P., Hao, Z., Jones, L. D., Haight, J., Sheng, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621355114 · Cited by 58
SULKOWSKA, M., Sulkowski, S., Skrzydlewska, E., & Farbiszewski, R. (1998) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(98)80085-7 · Cited by 57
Cancer stem cells as the engine of unstable tumor progression
Solé, R. V., Rodríguez‐Caso, C., Deisboeck, T. S., & Saldaña, J. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.03.034 · Cited by 49
The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells
Che, S., Zhang, X.-Z., Liu, X., Chen, X., & Hou, L. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01138.x · Cited by 47
Okamoto, T., Kohno, M., Ito, K., Takada, K., Katsura, M., Morodomi, Y., Toyokawa, G., Shoji, F., & Maehara, Y. (2017) · Anticancer Research · doi:10.21873/anticanres.11505 · Cited by 8
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
The role of cellular reactive oxygen species in cancer chemotherapy
Yang, H., Villani, R. M., Wang, H., Simpson, M. J., Roberts, M. S., Tang, M., & Liang, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0909-x · Cited by 794
Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat
Villalpando-Rodriguez, G. E., & Gibson, S. B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9912436 · Cited by 491
Micro(nano)plastics pollution and human health: How plastics can induce carcinogenesis to humans?
Kumar, R., Manna, C., Padha, S., Verma, A., Sharma, P., Dhar, A., Ghosh, A., & Bhattacharya, P. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134267 · Cited by 411
Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Oh, Y., & Jun, H.-S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010026 · Cited by 217
Metadata
- Authors
- de Sá Junior, P. L., Câmara, D. A. D., Porcacchia, A. S., Fonseca, P. M. M., Jorge, S. D., Araldi, R. P., & Ferreira, A. K.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2017-01
- Volume
- 2017
- Issue
- 1
- Pages
- 2467940-2467940
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2766112735
- Cited by
- 287
- References
- 111
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.